PhaseIII TrialBrandplanREMSProgramIndicationprioritizationAntibodydrugconjugateOverallresponserateSideeffectsPfizerUnmetneedsIndicationexpansionBiomarinForecastPDUFAFirst tomarketGenentechCAR-TTherapyGenericsBiomarkerGeneTherapyEpidemiologyDurabilityofresponsePeakopportunityLoss ofexclusivityAmgenPhaseIII TrialBrandplanREMSProgramIndicationprioritizationAntibodydrugconjugateOverallresponserateSideeffectsPfizerUnmetneedsIndicationexpansionBiomarinForecastPDUFAFirst tomarketGenentechCAR-TTherapyGenericsBiomarkerGeneTherapyEpidemiologyDurabilityofresponsePeakopportunityLoss ofexclusivityAmgen

Pharma Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Phase III Trial
  2. Brand plan
  3. REMS Program
  4. Indication prioritization
  5. Antibody drug conjugate
  6. Overall response rate
  7. Side effects
  8. Pfizer
  9. Unmet needs
  10. Indication expansion
  11. Biomarin
  12. Forecast
  13. PDUFA
  14. First to market
  15. Genentech
  16. CAR-T Therapy
  17. Generics
  18. Biomarker
  19. Gene Therapy
  20. Epidemiology
  21. Durability of response
  22. Peak opportunity
  23. Loss of exclusivity
  24. Amgen